(secondQuint)A Trial of Enteral Colostrum on Intestinal Permeability in Critically Ill Patients.

 A randomized, double blind, controlled trial will be conducted in general intensive care unit (ICU) in Tehran, Iran.

 After a full review of the inclusion and exclusion criteria and explanation of the risks and benefits of the study, written consent form will be completed.

 Intervention patients will be received 20 g/day of colostrum along with enteral formula and control patients will be received maltodextrin along with enteral formula.

 Patients will be evaluated for plasma endotoxin and plasma zonulin.

.

 A Trial of Enteral Colostrum on Intestinal Permeability in Critically Ill Patients@highlight

The effects of colostrum on intestinal permeability in critical ill patients has not been investigated.

 In current trial, intensive care unit patients with enteral feeding will receive either enteral colostrum or maltodextrin as placebo.

